Results 111 to 120 of about 34,148 (221)

Clinicopathological Features and Postoperative Complication Management of a Postauricular Granular Cell Tumor: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Postauricular granular cell tumors mimic parotid malignancies. Their resection disrupts fragile local microcirculation due to inherently thin skin and limited subcutaneous buffer, triggering ischemic necrosis and MRSE infection. Clinicians must prioritize functional tissue preservation and vigilant wound care to prevent these severe ...
Haotong Yuan, Chunhong Wang, Luran Wang, Dongxu Liu, Li Gao   +4 more
wiley   +1 more source

Moxifloxacin dosing in post-bariatric surgery patients

, 2014
Introduction Given the ever increasing number of obese patients and obesity related bypass surgery, dosing recommendations in the post-bypass population are needed. Using a population pharmacokinetic (PK) analysis and PK-pharmacodynamic (PD) simulations,
T'jollyn, Huybrecht, Colin, Pieter, De Waele, Jan, Eleveld, Douglas J., Struys, Michel, Eleveld, Douglas J, Struys, Michel M. R. F., Struys, Michel M. R. F.; id_orcid, Van Bocxlaer, Jan, Van Bortel, Lucas, Colin, Pieter; id_orcid, Ruige, Johannes, Van Bortel, Luc M., Boussery, Koen   +13 more
core   +1 more source

Adult Gonococcal Conjunctivitis Complicated by Peripheral Ulcerative Keratitis: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Neisseria gonorrhoeae conjunctivitis is rare in adults but may rapidly progress to vision‐threatening complications. Peripheral ulcerative keratitis (PUK) is an unusual and severe manifestation. A 42‐year‐old male presented with bilateral ocular pain, swelling, and profuse purulent discharge for 15 days, leading to inability to open his eyes ...
Prashim Sharma, Ramesh Bikram Khatri Chhetri, Alisha Adhikari, Badri Prasad Badhu, Prerna Arjyal Kafle   +4 more
wiley   +1 more source

Moxifloxacin Increases Heart Rate in Humans

, 2017
(1) Background: We assessed the effect of moxifloxacin on heart rate, and reviewed the heart rate effects of other antibiotics; (2) Methods: A total of 335 normal volunteers had 12-lead electrocardiograms recorded at multiple time points before and ...
Jay Mason, Jay W. Mason, Thomas Moon, Thomas E. Moon   +3 more
core   +1 more source

Conservative management of paediatric dacryocystitis: a collection of clinical experiences highlighting effectiveness and parental satisfaction

Drugs in Context
Paediatric dacryocystitis, often linked to congenital nasolacrimal duct obstruction, may require surgical intervention if local conservative treatment is ineffective.
Stefano Russo, Antonio Valentino Giugliano, Ida Cesarano, Luigi Di Perna, Ciro Picardi   +4 more
doaj   +1 more source

Pacritinib Impact on QT Interval: Results of a Thorough QT Study and Post Hoc Analysis of Prospective Clinical Trial Data

Clinical Pharmacology in Drug Development, Volume 15, Issue 6, June 2026.
Abstract Pacritinib, an inhibitor of JAK2/IRAK1/ACVR1 that is devoid of JAK1 activity, approved for treating myelofibrosis in patients with severe thrombocytopenia, carries a label warning for QT interval prolongation. To evaluate the cardiac safety of pacritinib, a randomized, placebo‐ and active‐controlled, single‐dose thorough QT (TQT) study was ...
Sarah A. Buckley, Suliman Al‐Fayoumi, James P. Dean, Jessica Zhang, Purvi Suthar, Muriel Richard   +5 more
wiley   +1 more source

Activity of moxifloxacin against mycobacteria

, 1999
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We tested its activity in comparison with four other quinolones and isoniazid against clinical isolates of mycobacteria. It proved to be the most active of the
Gillespie, S. H., Billington, O.
core   +1 more source

Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats

Frontiers in Pharmacology
ObjectiveMoxifloxacin (MFLX) frequently induces dysglycemia when used in the treatment of infectious diseases, particularly in patients with diabetes. However, the mechanism through which MFLX affects host glucose metabolism remains unclear.
Yewen Sun, Yewen Sun, Yuchen Qu, Zhuan Yang, Zhuan Yang, Bo Lv, Guanjun Wang, Guanjun Wang, Kai Fan, Yuyuan Wang, Jie Pan, Ziyan Du, Yunli Yu   +12 more
doaj   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

JEADV Clinical Practice, Volume 5, Issue 2, Page 627-631, June 2026.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, Kyle Cullingham   +4 more
wiley   +1 more source

Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

, 2008
Mauro Campos, Mariana Ávila, Anelise Wallau, Cristina Muccioli, Ana Luisa Höfling-Lima, Rubens Belfort JrDepartment of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo ...
Mariana Ávila, Ana Luisa Höfling-Lima, Rubens Belfort Jr, Mauro Campos, Anelise Wallau, Cristina Muccioli   +5 more
core